eFFECTOR Therapeutics, Inc. Warrant
EFTRW
EFTRW was delisted on the 2nd of July, 2024.
26 hedge funds and large institutions have $3.62M invested in eFFECTOR Therapeutics, Inc. Warrant in 2021 Q1 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LA
Linden Advisors
New York
|
+$292K |
| 2 |
ECP
Empyrean Capital Partners
Los Angeles,
California
|
+$270K |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$161K |
| 4 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
+$146K |
| 5 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$136K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| – | +$321 | +333 | New |
|
EFTRW Hedge Fund Activity: Q1 2021 in Review
26 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in eFFECTOR Therapeutics, Inc. Warrant (EFTRW) for Q1 2021, worth a combined $3.62M.
Buyers outnumbered sellers: 26 funds opened new EFTRW positions and 0 closed out — a net gain of 26 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Linden Advisors, opening a new position worth an estimated $292K.
- 26 institutional investors held eFFECTOR Therapeutics, Inc. Warrant (EFTRW) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $3.62M of eFFECTOR Therapeutics, Inc. Warrant stock for Q1 2021.
- 26 funds opened new eFFECTOR Therapeutics, Inc. Warrant positions in Q1 2021 and 0 closed out, a net change of +26 holders.
- The largest eFFECTOR Therapeutics, Inc. Warrant buyer in Q1 2021 was Linden Advisors, an estimated $292K added.
Based on aggregated 13F filings for Q1 2021.